Comments

First Trust Nasdaq Pharmaceuticals ETF Stock Price, Quotes and Forecasts

FTXHNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$24.04

0.471.99%

At close: -

$26.40

2.369.82%

After Hours: Apr 4, 7:00 AM EDT

Overview

News Holdings Dividends Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Sector

Healthcare

Region

AUM

13.00M

Fund Score

First Trust Nasdaq Pharmaceuticals ETF Price, Quotes and Forecasts | NASDAQ:FTXH | Benzinga

Explore First Trust Nasdaq Pharmaceuticals ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for FTXH.

Open	$23.69
High	$24.05
52 Wk High	$29.72
AUM	13.00M
Dividend	$0.39
Ex-Div Date	Jun 27, 2024
Volume	6.75K
Market Cap	$126.09B
Mgmt Fee	0.6%
P/E Ratio	22.24
Prev. Close	$23.57
Low	$23.41
52 Wk Low	$23.29
Shares Out	750.00K
Yield	1.38%
Div. Freq	Quarterly
Avg. Volume Daily	7.75K
Beta	0.66
Avg. Expense Ratio	0.6%
P/B Ratio	3.28

Recent News

Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies

Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face tariffs.

Rishabh Mishra

Federal Judge Halts National Institutes of Health's Grant Policy Overhaul Citing Legal Violations

A federal court blocked NIH's policy capping indirect cost rates on research grants, ruling it unlawful. The decision safeguards billions in funding and ongoing clinical trials.

Vandana Singh

Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies

Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.

Chandrima Sanyal

FAQ

How do I buy First Trust Nasdaq Pharmaceuticals ETF (FTXH) stock?

You can purchase shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) through any online brokerage.

View our list of the best stock brokerages

Who are First Trust Nasdaq Pharmaceuticals ETF (FTXH) competitors?

There are no as such competitors for First Trust Nasdaq Pharmaceuticals ETF.

What is the forecast, or price target, for First Trust Nasdaq Pharmaceuticals ETF (FTXH) stock?

There is no analysis for First Trust Nasdaq Pharmaceuticals ETF to provide a consensus price target.

What is the current price for First Trust Nasdaq Pharmaceuticals ETF (FTXH)?

The stock price for First Trust Nasdaq Pharmaceuticals ETF (NASDAQ: FTXH) is $24.04 last updated April 11, 2025 at 4:15 PM EDT.

Does First Trust Nasdaq Pharmaceuticals ETF (FTXH) pay a dividend?

A quarterly cash dividend of 0.13 per share of Class A Common Stock. The quarterly cash dividend was payable on December 31, 2024 to stockholders of record on December 13, 2024.

When is First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) reporting earnings?

First Trust Nasdaq Pharmaceuticals ETF does not have any upcoming earnings scheduled.

Is First Trust Nasdaq Pharmaceuticals ETF (FTXH) going to split?

There is no upcoming split for First Trust Nasdaq Pharmaceuticals ETF.

Open	$23.69
High	$24.05
52 Wk High	$29.72
AUM	13.00M
Dividend	$0.39
Ex-Div Date	Jun 27, 2024
Volume	6.75K
Market Cap	$126.09B
Mgmt Fee	0.6%
P/E Ratio	22.24
Prev. Close	$23.57
Low	$23.41
52 Wk Low	$23.29
Shares Out	750.00K
Yield	1.38%
Div. Freq	Quarterly
Avg. Volume Daily	7.75K
Beta	0.66
Avg. Expense Ratio	0.6%
P/B Ratio	3.28

About First Trust Exchange-Traded Fund III

Sector

N/A

Industry

N/A

Got Questions? Ask

What is FTXH's current price trend?

What is FTXH's drawdown from recent high?

What is FTXH's net income trend?

What is FTXH's operating cash flow?

What is FTXH's P/E ratio?

ETF Details

Sector	Healthcare
Category	High Performer-High Growth
Investment Style	Large Cap Blend
Fund Inception	Sep 20, 2016
Managers	David G. McGarel Chris A. Peterson Jon C. Erickson Stan Ueland Roger F. Testin Erik Russo Daniel J. Lindquist
Definition	An equity fund portfolio full of stocks with both strong financial performance and superior growth potential

Investment Policy

The Fund will normally invest at least 90 percent of its net assets (including investment borrowings) in the securities that comprise the Index. The Fund, using an indexing investment approach, attempts to replicate, before fees and expenses, the performance of the Index. The Index is owned and is developed, maintained and sponsored by Nasdaq, Inc. (the Index Provider). The Index Provider may, from time to time, exercise reasonable discretion as it deems appropriate in order to ensure Index integrity.

Top ETF Holdings

Symbol	Name	Share %
PFE	Pfizer, Inc.	7.13%
ABBV	Abbvie Inc.	7.58%
JNJ	Johnson & Johnson	7.13%
BMY	Bristol-Myers Squibb C...	7.67%
MRK	Merck & Company, Inc.	7.25%
UTHR	United Therapeutic	3.68%
AMGN	Amgen Inc.	3.83%
VRTX	Nvaesrtex Pharmaceutic...	4.02%
REGN	Regeneron Parmaceutica...	3.93%
GILD	Gilead Sciences Inc	3.74%
CAH	Cardinal Health Inc.	4.32%
JAZZ	Jazz Pharmaceuticals P...	3.95%
LLY	Eli Lilly & Co.	3.60%
ZTS	Zoetis Inc .	3.72%
BIIB	Biogen Inc. Com	3.61%